UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Ted Buchan & Co

Ted Buchan & Co lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 32.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,671 shares of the healthcare conglomerate's stock after buying an additional 1,393 shares during the period. UnitedHealth Group makes up 1.4% of Ted Buchan & Co's investment portfolio, making the stock its 20th largest holding. Ted Buchan & Co's holdings in UnitedHealth Group were worth $2,869,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in UnitedHealth Group in the 4th quarter valued at $6,375,744,000. Raymond James Financial Inc. acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $1,914,740,000. Amundi increased its position in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares during the period. Proficio Capital Partners LLC lifted its position in UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after acquiring an additional 1,886,186 shares during the period. Finally, Franklin Resources Inc. increased its holdings in shares of UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Remove Ads

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $15.50 during mid-day trading on Friday, hitting $524.94. 9,914,705 shares of the company were exchanged, compared to its average volume of 4,256,040. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $480.17 billion, a P/E ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business's 50 day simple moving average is $509.24 and its two-hundred day simple moving average is $541.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on UNH shares. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Finally, Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.